© 2021 MJH Life Sciences™ and Diagnostic Imaging. All rights reserved.
MRI
Whole-Body MRI Outperforms PET/CT in Multiple Myeloma Detection
January 22, 2021
Whole-body MRI was able to detect more lesions and identify more patients for earlier treatment.
Looking to Reduce Bone Pain from Cancer? Consider MR-Guided HIFU
January 19, 2021
Pairing MR-guided high intensity focused ultrasound with the standard-of-care, external beam radiotherapy, can offer faster pain relief to patients.
MRI-Guided Breast Biopsy Could Provide Non-Invasive Evaluation of Response to Neoadjuvant Treatment
January 18, 2021
Using MRI-guided biopsy could help women avoid surgical resection to determine how well chemotherapy is working.
Diagnostic Imaging's A Look Ahead: Jan. 18, 2021, to Jan. 22, 2021
January 18, 2021
Here's what to expect this week on Diagnostic Imaging.
MRI AI Tool Could Lead to More Targeted Prostate Cancer Treatment
January 17, 2021
Using pre-operative MRI data, an AI algorithm can help predict recurrence better than existing models.
Hyperfine’s Image Assessment Software Captures FDA Clearance
January 16, 2021
Software provides annotated and segmented brain images captured by Hyperfine’s portable MRI system.
Diagnostic Imaging's Weekly Scan: Jan. 11 to Jan. 15, 2021
January 15, 2021
COVID-19 and Long-Term Lung Effects; Reduce Emergency Department Imaging Recalls; COVID-19, Myocarditis, and Athletes; Plus, New Recommendation for X-ray Gonad Shielding
Breast MRI-Identified Lesions During Neoadjuvant Therapy Are Largely Benign
January 15, 2021
Suspicious lesions that develop during neoadjuvant therapy are uncommon, and they are highly unlikely to be malignant.
Non-Invasive Imaging Can Measure Cell Dysfunction in Patients with ALS
January 14, 2021
A new magnetic resonance spectroscopy technique can accurately measure how well the mitochondria are functioning in this patient group, potentially facilitating more effective therapies.